Autotransfusion Devices Market Size

  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Autotransfusion Devices Market Size

Autotransfusion Devices Market size was valued at USD 285.15 million in 2024 and is poised to cross USD 652.68 million by the end of 2037, registering more than 6.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of autotransfusion devices is estimated at USD 300.21 million.

The growth of the market can primarily be ascribed to the number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018 across the globe. Moreover, instances of surgical burden are to expected rise by approximately 30% in the next few years.

The rising need for blood donation and increased volumes of donated blood, combined with the rising need for blood transfusion, is expected to boost the growth of the global autotransfusion devices market. As per the reported data, globally, every year about 118.5 million units of donated blood are collected. Additionally, in India, nearly 25-30 thousand people require liver transplants and about 50,000 person gets a heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdom.

Autotransfusion is the procedure of transferring a patient's own blood into their body during cardiac or orthopedic surgery after component separation, and filtration. On the other hand, allogeneic blood transfusions can result in tumor progression, post-operative infections, severe lung injury, post-operative cardiovascular failures, and early death. For instance, multiple patient-based analysts predict that the pervasiveness of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) in the United States is about 1.0% and 0.1%, respectively. As a result, shifting the priority forward into cell salvage can greatly decrease the need for allogeneic blood transfusion, decreasing the likelihood of detrimental ailments. As a result, the switch toward autologous blood transfusion is an eminent trend that is predicted to drive the market’s growth.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of autotransfusion devices is estimated at USD 300.21 million.

The autotransfusion devices market size was valued at USD 285.15 million in 2024 and is poised to cross USD 652.68 million by the end of 2037, registering more than 6.7% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery will impel the market growth.

Asia Pacific industry is anticipated to expand at the fastest CAGR through 2037, owing to entry of new industry players, and increasing acceptance of cell salvage technologies.

The major players in the market include ProCell Surgical Inc, .BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample